Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
HR-QoL and Sexuality in Mirena Inserted Contraception Users
ClinicalTrials.gov study NCT00498784. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma
ClinicalTrials.gov study NCT07029776. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locall
ClinicalTrials.gov study NCT06312176. IPD Sharing: YES. Countries: 40. Publications: 0.
Integrated Testing Strategy for Simultaneous Detection of ESR-1 and GBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,
ClinicalTrials.gov study NCT06762483. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gene Expression Profiling to Help Define the Need for Neo-Adjuvant Chemotherapy in HR+, HER- Breast Cancer Patients
ClinicalTrials.gov study NCT05666258. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)
ClinicalTrials.gov study NCT07190443. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT06075758. IPD Sharing: NO. Countries: 4. Publications: 0.
Elacestrant and Exemestane for Patients With Pretreated HR+/HER2- Metastatic Breast Cancer and [18F] FES-avid Lesions (COMBINE)
ClinicalTrials.gov study NCT07395336. IPD Sharing: NO. Countries: 0. Publications: 0.
FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy
ClinicalTrials.gov study NCT06185569. IPD Sharing: NO. Countries: 1. Publications: 0.
HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)
ClinicalTrials.gov study NCT07379190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer
ClinicalTrials.gov study NCT06587789. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
ClinicalTrials.gov study NCT03326674. IPD Sharing: UNDECIDED. Countries: 19. Publications: 0.
Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration
ClinicalTrials.gov study NCT07307456. IPD Sharing: NO. Countries: 1. Publications: 0.
Normative Database for HR-pQCT-Based Radius and Tibia Strength
ClinicalTrials.gov study NCT03219099. IPD Sharing: NO. Countries: 1. Publications: 0.
A Real-world Study of Effectiveness and Safety in HR+/HER2- Breast Cancer Patients Treated With Ribociclib or Alpelisib
ClinicalTrials.gov study NCT06705504. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation.
ClinicalTrials.gov study NCT00568945. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Rec
ClinicalTrials.gov study NCT06851442. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer
ClinicalTrials.gov study NCT05949541. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection
ClinicalTrials.gov study NCT05283239. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
ClinicalTrials.gov study NCT06106477. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.